Redian新闻
>
Biotech Takeover Fever, Who's next after Imclone Deal
avatar
Biotech Takeover Fever, Who's next after Imclone Deal# Stock
e*7
1
BMY-IMCL deal gets done and may be in a higher price around 65-70. IMCL
jumped 20 to 65 from yesterday's close of 45.
Here are the list of comapnies on speculation list of future dating game:
Amylin/Eli Lilly (Byetta); OSI/Genentech (Tarceva); Biogen/Genentech (
Rituxan); Genzyme/BioMarin (Aldurazyme); Vertex/JNJ (Telapravir); Human
Genome Sciences/Novartis & GSK (Albuferon & LymphoSTAT); Regeneron/Sanofi (
VEGF-TRAP) ; Onyx/Bayer (Nexavaar); Idenix/Novartis (various compounds) ;
Momenta/Novarti
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。